These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 20626604

  • 1. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ, Choi HK, Ahn TY, Park JK, Chung WS, Lee SW, Kim SW, Hyun JS, Park NC.
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
    Paick JS, Ahn TY, Choi HK, Chung WS, Kim JJ, Kim SC, Kim SW, Lee SW, Min KS, Moon KH, Park JK, Park K, Park NC, Suh JK, Yang DY, Jung HG.
    J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
    Paick JS, Kim JJ, Kim SC, Moon KH, Min KS, Park K, Suh JK, Yang DY.
    J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
    Du W, Li J, Fan N, Shang P, Wang Z, Ding H.
    Aging Male; 2014 Jun; 17(2):107-11. PubMed ID: 24219508
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
    Ortaç M, Çayan S, Çalişkan MK, Yaman MÖ, Okutucu TM, Semerci MB, Altay AB, Balbay MD, Özcan MF, Kadioğlu A.
    Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of udenafil [Zydena] for the treatment of erectile dysfunction in hypertensive men taking concomitant antihypertensive agents.
    Paick JS, Kim SW, Park YK, Hyun JS, Park NC, Lee SW, Park K, Moon KH, Chung WS.
    J Sex Med; 2009 Nov; 6(11):3166-76. PubMed ID: 19694927
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F, Aversa A, Moncada I, Perimenis P, Porst H, Barker C, Shane MA, Sorsaburu S.
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Mirodenafil Oro-Dispersible Film in Korean Patients with Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Phase IV Study.
    Lee SW, Son H, Lee SW, Cho KS, Moon DG, Yang DY, Chung WS, Suh JK, Park HJ, Min K, Moon KH, Park K, Park JK, Hyun JS, Yang SK.
    World J Mens Health; 2022 Apr; 40(2):280-289. PubMed ID: 33987996
    [Abstract] [Full Text] [Related]

  • 12. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
    Moon du G, Yang DY, Lee CH, Ahn TY, Min KS, Park K, Park JK, Kim JJ.
    J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, Paick JS, Ahn TY, Min KS, Park K, Park JK.
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
    Park HJ, Park JK, Park K, Min K, Park NC.
    J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
    [Abstract] [Full Text] [Related]

  • 15. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H, Gacci M, Büttner H, Henneges C, Boess F.
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial.
    Park SY, Choi GS, Park JS, Kim HJ, Park JA, Choi JI.
    Surgery; 2015 Jan; 157(1):64-71. PubMed ID: 25482466
    [Abstract] [Full Text] [Related]

  • 18. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S.
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.
    Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, Paick JS, Ahn TY, Moon KH, Chung WS, Min KS, Suh JK, Hyun JS, Park K, Park JK.
    BJU Int; 2012 Dec; 110(11):1801-6. PubMed ID: 22448738
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T, Gleissner J, Merfort F, Hermanns M, Beneke M, Ulbrich E.
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.